Relugolix tablets are a drug used to treat heavy menstrual bleeding and endometriosis pain associated with uterine fibroids, and are produced by Takeda Corporation of Japan. This article will introduce the relevant information of Relugolix tablets in detail from three aspects: price, medication instructions and precautions, to help patients better understand and use the drug.
Relugolix tablets price
The price of Relugolix tablets is the focus of many patients. Understanding its market pricing helps to reasonably plan the treatment budget.
Market price and specifications
Relugolix tablets are produced by Takeda Corporation of Japan, with a specification of 40mg*100 tablets, and the reference price is about US$151 per box. This price may fluctuate depending on the region and purchase channel.
Purchase channel and medical insurance situation
Currently, Relugolix tablets have not been listed in China and have not been included in the medical insurance catalog. Patients can purchase them through regular medical service institutions or cross-border e-commerce platforms, but they must pay attention to the authenticity and production date of the drugs to avoid purchasing counterfeit or inferior drugs.
After understanding the price and purchase channels of Relugolix tablets, patients can arrange treatment plans more reasonably. Next, we will introduce the medication instructions of this drug in detail.
Guidelines for the use of Relugolix tablets
The correct method of medication is important for the treatment effect. The following is the usage and dosage of Relugolix tablets and related recommendations.
Recommended dosage and method of administration
The recommended dose of Relugolix tablets is one tablet per day, which should be taken at the same time to maintain blood drug concentration. It can be taken before or after meals, but it should be avoided to use it at the same time as P-gp inhibitors. If you miss a dose, you should take it as soon as possible and resume the normal medication time the next day.
Medication recommendations for special populations
Pregnant women are prohibited from using Relugolix tablets, and breastfeeding women should use it with caution. Patients with reproductive potential should take non-hormonal contraceptive measures during treatment and for at least one week after stopping the drug. The safety of pediatric patients has not yet been determined and needs to be used under the guidance of a doctor.
After mastering the correct method of medication, patients also need to understand the precautions of Relugolix tablets to avoid potential risks.
Precautions for the use of Relugolix tablets
When using Relugolix tablets, be alert to adverse reactions and drug interactions. The following are the contents that need special attention.
Common adverse reactions
Relugolix tablets may cause adverse reactions such as vasomotor symptoms, uterine bleeding, and hair loss. Patients with endometriosis may also experience symptoms such as headaches, mood disorders, and nausea. If severe discomfort occurs, seek medical attention immediately.
Drug interactions and contraindications
Relugolix tablets combined with P-gp inhibitors or strong CYP3A inducers may affect the efficacy of the drug. Contraindications include thromboembolic diseases, osteoporosis, and liver damage. Patients need to monitor liver function and bone density regularly to ensure drug safety.
By understanding the price, medication instructions, and precautions of Relugolix tablets, patients can use the drug more safely and effectively to achieve the best therapeutic effect.
